No Data
Insiders At ANI Pharmaceuticals Sold US$8.8m In Stock, Alluding To Potential Weakness
Earnings Preview: ANIP to Report Financial Results Pre-market on February 28
ANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in March
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 A.m. ET
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results From the Generic Pharmaceuticals Group
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Shareholders Respectable 19% CAGR Over 3 Years, Surging 5.9% in the Last Week Alone
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}